Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Tuesday 06 August, 2019

Morgan Stanley&CoLLC

Rule 38.5 - ALLERGAN PLC

RNS Number : 0933I
Morgan Stanley & Co. LLC
06 August 2019
 

 

 FORM 38.5

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER  RULES, 2007 (AS AMENDED)

 

DEALINGS BY CONNECTED EXEMPT MARKET-MAKERS

 

1.             KEY INFORMATION

 Name of exempt market-maker

   Morgan Stanley & Co. LLC

 Company dealt in

   ALLERGAN PLC

 Class of relevant security to which the dealings being disclosed relate (Note 1)

  US$0.0001 ORDINARY SHARES

 Date of dealing

   05 AUGUST 2019

 

 

2.             DEALINGS (Note 2)

 

(a)           Purchases and sales

 Total number of relevant secuities accquired

 Highest price paid (Note 3)

 Lowest price paid (Note 3)

  565,966

 161.1100 USD

 159.8133 USD

 

 Total number of relevant secuities disposed

 Highest price paid (Note 3)

 Lowest price paid (Note 3)

  593,072

 161.1100 USD

 159.6000 USD

 

 

(b)           Derivatives transactions (other than options transactions)

 

 Product name, e.g. CFD

 Nature of transaction

                (Note 4)

 Number of relevant securities

                (Note 5)

 Price per unit

 N/A

 N/A

 N/A

 N/A

 

 

(c)            Options transactions in respect of existing relevant securities

 

i)           Writing, selling, purchasing or varying

 

 Product name, eg call option

 Writing, selling, purchasing, varying etc

 Number of securities to which the option relates (Note 5)

 Exercise Price

 Type, e.g American, European etc

 Expiry Date

 Option money paid/received per unit (Note 3)

 CALL

 PURCHASE

 100

 165.0000

A

 09/08/2019

 0.2100 USD

 PUT

 PURCHASE

 300

 160.0000

A

 16/08/2019

 1.6100 USD

 CALL

 SALE

 2,500

 170.0000

A

 16/08/2019

 0.0700 USD

 CALL

 SALE

 100

 200.0000

A

 17/01/2020

 0.1300 USD

 CALL

 SALE

 400

 190.0000

A

 17/01/2020

 0.2400 USD

 CALL

 SALE

 400

 190.0000

A

 17/01/2020

 0.2400 USD

 CALL

 SALE

 200

 165.0000

A

 09/08/2019

 0.2600 USD

 CALL

 SALE

 200

 165.0000

A

 09/08/2019

 0.2600 USD

 CALL

 SALE

 100

 165.0000

A

 09/08/2019

 0.3200 USD

 CALL

 SALE

 200

 165.0000

A

 16/08/2019

 0.3400 USD

 PUT

 SALE

 500

 157.5000

A

 09/08/2019

 0.6600 USD

 PUT

 SALE

 500

 157.5000

A

 09/08/2019

 0.6600 USD

 PUT

 SALE

 3,000

 157.5000

A

 09/08/2019

 0.7400 USD

 CALL

 SALE

 100

 162.5000

A

 09/08/2019

 0.7800 USD

 CALL

 SALE

 100

 162.5000

A

 09/08/2019

 0.7800 USD

 CALL

 SALE

 800

 162.5000

A

 16/08/2019

 0.8100 USD

 PUT

 SALE

 100

 160.0000

A

 09/08/2019

 1.3700 USD

 PUT

 SALE

 100

 160.0000

A

 16/08/2019

 1.9700 USD

 CALL

 SALE

 100

 160.0000

A

 09/08/2019

 2.0400 USD

 

(ii) Exercising

 

 Product name, eg call option

 Number of securities

 Exercise price per unit (Note 3)

 N/A

 N/A

 N/A 

 

 

3. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 Date of disclosure

 06 AUGUST 2019

 Contact Name

Craig Horsley

 Telephone Number

+44(141) 245 7736

 Name of offeree/offeror with which connected

ABBVIE INC.

Nature of connection (Note 6)

Advisory

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISELIFEATLIRIIA

a d v e r t i s e m e n t